Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity.

BACKGROUND AND PURPOSE The purpose of this study was to investigate the possibility of obtaining prognostic indications in patients with internal carotid occlusion on the basis of intracranial hemodynamic status, presence of previous symptoms of cerebrovascular failure, and baseline characteristics. METHODS Cerebral hemodynamics were studied with transcranial Doppler ultrasonography. Cerebrovascular reactivity to apnea was calculated by means of the breath-holding index (BHI) in the middle cerebral arteries. Sixty-five patients with internal carotid artery occlusion were followed-up prospectively (median, 24 months), 23 patients were asymptomatic and 42 symptomatic (20 with transient ischemic attack and 22 with stroke). RESULTS During the follow-up period, 11 symptomatic patients and 1 asymptomatic patient had another ischemic event ipsilateral to carotid occlusion. Among factors considered, only lower BHI values in the middle cerebral arteries ipsilateral to carotid occlusion and older age were significantly associated with the risk of developing symptoms (P=0.002 and P=0.003, respectively; Cox regression multivariate analysis). Based on our data, a cut point of the BHI value for distinguishing between pathological and normal cerebrovascular reactivity was determined to be 0.69. All patients except one, who developed TIA or stroke during the follow-up period, had BHI values ipsilateral to carotid occlusion of <0.69. CONCLUSIONS These data suggest that impaired cerebrovascular reactivity is predictive for cerebral ischemic events in patients with carotid occlusion.

[1]  Y Yonekura,et al.  Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[2]  R. Aaslid,et al.  Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. , 1982, Journal of neurosurgery.

[3]  N. Bornstein,et al.  Benign outcome of carotid occlusion , 1989, Neurology.

[4]  G. Bernardi,et al.  Effect of Smoking on Cerebrovascular Reactivity , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  H Yonas,et al.  Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. , 1995, Journal of vascular surgery.

[6]  W J Powers,et al.  Increased oxygen extraction fraction is associated with prior ischemic events in patients with carotid occlusion. , 1998, Stroke.

[7]  R. Aaslid,et al.  Cerebral autoregulation dynamics in humans. , 1989, Stroke.

[8]  K. Minematsu,et al.  Effect of Acetazolamide Reactivity and Long-term Outcome in Patients With Major Cerebral Artery Occlusive Diseases , 1998 .

[9]  W J Powers,et al.  Influence of cerebral hemodynamics on stroke risk: One‐year follow‐up of 30 medically treated patients , 1989, Annals of neurology.

[10]  P. Hedera,et al.  Compressions of Carotid and Vertebral Arteries in Assessment of Intracranial Collateral Flow: Correlation Between Angiography and Transcranial Doppler Ultrasonography , 1994, Angiology.

[11]  C. Bladin,et al.  frequency and pathogenesis of hemodynamic stroke , 1994, Stroke.

[12]  J. Bray,et al.  Quantification of Atheromatous Stenosis in the Extracranial Internal Carotid Artery , 1995 .

[13]  H Yonas,et al.  Increased stroke risk predicted by compromised cerebral blood flow reactivity. , 1993, Journal of neurosurgery.

[14]  E B Ringelstein,et al.  Evaluation of Cerebral Vasomotor Reactivity by Various Vasodilating Stimuli: Comparison of CO2 to Acetazolamide , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  P. Hedera,et al.  Effect of collateral flow patterns on outcome of carotid occlusion. , 1995, European neurology.

[16]  B. Widder,et al.  Course of Cerebrovascular Reactivity in Patients With Carotid Artery Occlusions , 1994, Stroke.

[17]  N L Browse,et al.  Transcranial Doppler measurement of middle cerebral artery blood flow velocity: a validation study. , 1986, Stroke.

[18]  P A Schneider,et al.  Noninvasive assessment of CO2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions. , 1988, Stroke.

[19]  P. Coyle,et al.  Collateral development after carotid artery occlusion in Fischer 344 rats. , 1990, Stroke.

[20]  M. Hennerici,et al.  Spontaneous history of asymptomatic internal carotid occlusion. , 1986, Stroke.

[21]  J. Bamford,et al.  Classification and natural history of clinically identifiable subtypes of cerebral infarction , 1991, The Lancet.

[22]  B. Widder,et al.  Course of Carotid Artery Occlusions With Impaired Cerebrovascular Reactivity , 1992, Stroke.

[23]  C. Tulleken,et al.  Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. , 1997, Stroke.

[24]  A. Valentin,et al.  Evaluation of Vasomotor Reactivity by Transcranial Doppler and Acetazolamide Test Before and After Extracranial–Intracranial Bypass in Patients With Internal Carotid Artery Occlusion , 1992, Stroke.

[25]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[26]  F W Sharbrough,et al.  Cerebral blood flow measurements and electroencephalograms during carotid endarterectomy. , 1975, Journal of neurosurgery.

[27]  G. Anzola,et al.  Transcranial Doppler sonography and magnetic resonance angiography in the assessment of collateral hemispheric flow in patients with carotid artery disease. , 1995, Stroke.

[28]  H. Markus,et al.  Estimation of Cerebrovascular Reactivity Using Transcranial Doppler, Including the Use of Breath‐Holding as the Vasodilatory Stimulus , 1992, Stroke.

[29]  C. Tulleken,et al.  A New Type of Extracranial/Intracranial Bypass for Recurrent Haemodynamic Transient Ischaemic Attacks , 1998, Cerebrovascular Diseases.